TIAA CREF Investment Management LLC reduced its stake in LHC Group (NASDAQ:LHCG) by 2.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 127,145 shares of the health services provider’s stock after selling 2,833 shares during the period. TIAA CREF Investment Management LLC owned approximately 0.70% of LHC Group worth $6,853,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of LHCG. FMR LLC boosted its stake in shares of LHC Group by 14.1% in the first quarter. FMR LLC now owns 1,619,899 shares of the health services provider’s stock worth $87,312,000 after buying an additional 199,849 shares during the period. Ameriprise Financial Inc. boosted its stake in shares of LHC Group by 17.7% in the first quarter. Ameriprise Financial Inc. now owns 542,738 shares of the health services provider’s stock worth $29,254,000 after buying an additional 81,554 shares during the period. State Street Corp boosted its stake in shares of LHC Group by 7.8% in the fourth quarter. State Street Corp now owns 373,936 shares of the health services provider’s stock worth $17,094,000 after buying an additional 26,915 shares during the period. Hood River Capital Management LLC boosted its stake in shares of LHC Group by 46.3% in the first quarter. Hood River Capital Management LLC now owns 252,054 shares of the health services provider’s stock worth $13,586,000 after buying an additional 79,752 shares during the period. Finally, Norges Bank bought a new stake in shares of LHC Group during the fourth quarter worth $7,913,000. Institutional investors and hedge funds own 84.97% of the company’s stock.

Shares of LHC Group (LHCG) traded up 2.12% on Tuesday, hitting $63.95. The stock had a trading volume of 221,255 shares. The stock has a 50 day moving average price of $64.12 and a 200-day moving average price of $56.24. LHC Group has a 12-month low of $32.04 and a 12-month high of $69.35. The company has a market cap of $1.13 billion, a price-to-earnings ratio of 28.30 and a beta of 0.77.

LHC Group (NASDAQ:LHCG) last issued its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.54 by $0.09. The firm had revenue of $260.20 million for the quarter, compared to analysts’ expectations of $254.10 million. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. LHC Group’s revenue was up 15.1% on a year-over-year basis. During the same quarter last year, the company posted $0.52 earnings per share. On average, equities analysts expect that LHC Group will post $2.39 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “TIAA CREF Investment Management LLC Reduces Position in LHC Group (LHCG)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/08/08/lhc-group-lhcg-shares-sold-by-tiaa-cref-investment-management-llc-updated-updated-updated.html.

LHCG has been the subject of a number of analyst reports. Royal Bank Of Canada restated a “buy” rating and set a $69.00 price objective on shares of LHC Group in a research note on Monday, May 15th. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $68.00 price target (up from $55.00) on shares of LHC Group in a research note on Monday, May 8th. Zacks Investment Research cut LHC Group from a “buy” rating to a “hold” rating in a research note on Thursday, July 6th. Jefferies Group LLC increased their price target on LHC Group from $56.00 to $65.00 and gave the company a “buy” rating in a research note on Monday, May 15th. Finally, BidaskClub cut LHC Group from a “buy” rating to a “hold” rating in a research note on Tuesday, July 25th. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $65.75.

In related news, COO Donald Dwayne Stelly sold 3,181 shares of the firm’s stock in a transaction that occurred on Thursday, June 8th. The shares were sold at an average price of $64.97, for a total transaction of $206,669.57. Following the transaction, the chief operating officer now owns 114,235 shares in the company, valued at $7,421,847.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Coliseum Capital Management, L sold 162,524 shares of the firm’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $62.80, for a total transaction of $10,206,507.20. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 682,839 shares of company stock worth $42,140,531. Corporate insiders own 14.80% of the company’s stock.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Stock Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related stocks with our FREE daily email newsletter.